Key result
[18F]FEDAC PET-CT visualizes acute myocardial ischemia with up to ~10-fold normal-to-ischemic uptake ratios.
Why the study?
The myocardial biodistribution, kinetics, and feasibility of [18F]FEDAC targeting translocator protein TSPO for early detection of mitochondrial dysfunction secondary to myocardial ischemia needed to be evaluated.
Does [18F]FEDAC micro-PET-CT imaging detect decreased TSPO expression and mitochondrial dysfunction in a rat model of acute myocardial ischemia-reperfusion injury?
Does [18F]FEDAC micro-PET-CT imaging detect decreased TSPO expression and mitochondrial dysfunction in a rat model of acute myocardial ischemia-reperfusion injury?
Answers are grounded in this paper and cite their sources.
[18F]FEDAC PET-CT non-invasively detects decreased TSPO expression corresponding to acute mitochondrial dysfunction in ischemic rat myocardium, demonstrating preclinical feasibility as a molecular imaging biomarker for early myocardial injury.
Background This study aimed to evaluate the biodistribution and kinetics of [18F]FEDAC targeting the translocator protein TSPO in the myocardium, and to explore its use for the identification of mitochondrial dysfunction. We also assessed the feasibility of [18F]FEDAC for the early detection of mitochondrial dysfunction associated with myocardial ischemia (MI). Methods The radiochemical purity and stability of [18F]FEDAC were analyzed by radio-high-performance liquid chromatography (radio-HPLC). Its biodistribution and kinetics were evaluated by dissection and dynamic imaging using micro-positron emission tomography–computed tomography (micro-PET–CT) in healthy mice. [18F]FEDAC was also applied in an MI rat model and in sham-operated controls. Mitochondrial changes were observed by immunohistochemical staining and electron microscopy. Results Radioactivity levels (%ID/g) in the myocardium in normal mice, determined by [18F]FEDAC, were 8.32 ± 0.80 at 5 min and 2.40 ± 0.10 at 60 min. PET showed significantly decreased uptake by injured cardiac tissue in MI rats, with maximal normal-to-ischemic uptake ratios of 10.47 ± 3.03 (1.5 min) and 3.92 ± 1.12 (27.5 min) (P = 0.025). Immunohistochemistry confirmed that TSPO expression was decreased in MI rats. Mitochondrial ultrastructure demonstrated significant swelling and permeability. Conclusion [18F]FEDAC uptake is reduced in the injured myocardium, consistent with mitochondrial dysfunction. These results may provide new evidence to aid the early detection of mitochondrial dysfunction associated with myocardial ischemic injury.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2021) studied Myocardial ischemia and mitochondrial dysfunction (n=28). [18F]FEDAC micro-PET-CT imaging vs. Sham-operated / normal control rats and non-ischemic myocardium was evaluated on Maximal normal-to-ischemic myocardial uptake ratio of [18F]FEDAC in MI model rats (p=0.025). [18F]FEDAC PET-CT showed reduced uptake in ischemic rat myocardium with maximal normal-to-ischemic uptake ratios of 10.47±3.03 at 1.5 min and 3.92±1.12 at 27.5 min.
Synapse has enriched 10 related papers. Consider them for comparative context: